Core A: Advanced Proteomics Core

Information

  • Research Project
  • 10245026
  • ApplicationId
    10245026
  • Core Project Number
    P01HL146366
  • Full Project Number
    5P01HL146366-03
  • Serial Number
    146366
  • FOA Number
    PAR-18-405
  • Sub Project Id
    8479
  • Project Start Date
    9/1/2019 - 4 years ago
  • Project End Date
    8/31/2024 - 2 months from now
  • Program Officer Name
    SCHRAMM, CHARLENE A
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    03
  • Suffix
  • Award Notice Date
    8/19/2021 - 2 years ago

Core A: Advanced Proteomics Core

PROJECT SUMMARY/ABSTRACT CORE A ? ADVANCED PROTEOMICS CORE The goal of Core A is to provide mass spectrometry?based proteomic platforms for global and targeted characterization of transcriptional regulators that play a central role in cardiac development and congenital heart defects in support of the aims and efforts for Projects 1?3 of the proposed PPG Project. We are continuously developing new and innovative strategies for more sensitive and quantitative analysis of protein- protein interactions (PPIs) and post-translational modifications (PTMs). These efforts now allow us to look beyond static PPIs or PTMs and towards more dynamic characterization in the context of different developmental stages, gene knockouts or gene mutations. Our affinity-purification mass spectrometry (AP-MS) capabilities along with newly developed proximity-based biotinylation (APEX-MS), will aid research in Projects 1?3 through dynamic interaction network mapping for transcriptional regulators, such as GATA4, TBX5, MEF2C, Myocardin and BAF complex members. Also, our quantitative analyses pipeline to determine PTMs on specific proteins will provide direct support for researchers in Project 3, focused on MEF2C and Myocardin, two signal responsive factors. All of these experiments will be performed in relevant systems for cardiac development, either induced pluripotent stem cell (iPSC)- or embryonic stem cell (ESC)-derived cardiac precursors (CPs), as well as cardiomyocytes (CMs) or cardiac tissue derived from neonatal mice. Beyond support of the projects, Core A will work closely with Core B to develop analysis strategies for APEX-MS data. The expertise, the highly sensitive and quantitative MS analysis, as well as ongoing innovations provided by Core A will serve and adapt to the needs of Projects and Cores of the PPG project.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    P01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    228115
  • Indirect Cost Amount
    149820
  • Total Cost
  • Sub Project Total Cost
    377935
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NHLBI:377935\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    HLBP
  • Study Section Name
    Heart, Lung, and Blood Initial Review Group
  • Organization Name
    J. DAVID GLADSTONE INSTITUTES
  • Organization Department
  • Organization DUNS
    099992430
  • Organization City
    SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    941582261
  • Organization District
    UNITED STATES